Through the issuance of two guidance documents on January 6, the US Food and Drug Administration (FDA) indicated it will limit the regulation of wearable devices that provide non-medical information as well as rules on clinical decision support software such as ChatGPT.
FDA Commissioner Marty Makary announced the new documents on

